Kant Ravi, Prajapati Megha, Das Pradip, Kanaras Antonios G, Saluja Daman, Christodoulides Myron, Ravi Kant Chhaya
Medical Biotechnology Laboratory, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India.
Molecular Microbiology, School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, U.K.
ACS Appl Mater Interfaces. 2025 Apr 9;17(14):20628-20646. doi: 10.1021/acsami.4c15851. Epub 2025 Mar 27.
The emergence of drug-resistant superbugs poses a critical global health threat, necessitating innovative treatment strategies. (Ng) causes a sexually transmitted disease called gonorrhea, and the bacterium has shown alarming resistance to conventional antibiotics, underscoring the urgent need for novel therapeutic approaches. In the current study, we interfaced computational biology and materials science to investigate the interactions between in-house synthesized metal-organic frameworks (MOFs) and the penicillin-binding protein 2 (PBP2) of Ng, a key target for β-lactam antibiotics. Using molecular docking and interaction analyses, we identified three promising MOFs, namely, Fe-BDC-258445, Cu-BDC-687690, and Ni-BDC-638866, with optimum binding scores and stable interactions. These scores indicated strong interactions with PBP2, suggesting their potential as therapeutic agents. Antimicrobial screening using a standard disk diffusion assay demonstrated that the Cu-BDC MOFs were bactericidal for multiple strains of Ng, whereas the Ni-BDC and Fe-BDC MOFs were nonbactericidal. The Cu-BDC MOF did not kill other Gram-negative bacteria, thus demonstrating specificity for Ng, and showed low toxicity for human Chang conjunctival epithelial cells . No significant leaching with biological activity was observed for the Cu-BDC MOF, and microscopy demonstrated the loss of gonococcal piliation and damage to the cell membrane. These findings underscore the potential of Cu-BDC MOFs as antimicrobial agents for further development.
耐药超级细菌的出现对全球健康构成了严重威胁,因此需要创新的治疗策略。淋病奈瑟菌(Ng)会引发一种名为淋病的性传播疾病,而且这种细菌已对传统抗生素表现出惊人的耐药性,凸显了对新型治疗方法的迫切需求。在当前的研究中,我们将计算生物学与材料科学相结合,以研究内部合成的金属有机框架(MOF)与淋病奈瑟菌的青霉素结合蛋白2(PBP2)之间的相互作用,PBP2是β-内酰胺类抗生素的关键靶点。通过分子对接和相互作用分析,我们确定了三种有前景的MOF,即Fe-BDC-258445、Cu-BDC-687690和Ni-BDC-638866,它们具有最佳的结合分数和稳定的相互作用。这些分数表明它们与PBP2有强烈的相互作用,暗示了它们作为治疗剂的潜力。使用标准纸片扩散法进行的抗菌筛选表明,Cu-BDC MOF对多种淋病奈瑟菌菌株具有杀菌作用,而Ni-BDC和Fe-BDC MOF则无杀菌作用。Cu-BDC MOF不会杀死其他革兰氏阴性菌,因此证明了其对淋病奈瑟菌的特异性,并且对人结膜上皮细胞的毒性较低。未观察到Cu-BDC MOF有明显的生物活性浸出,显微镜检查显示淋球菌菌毛丧失和细胞膜受损。这些发现强调了Cu-BDC MOF作为抗菌剂进一步开发的潜力。